Resolved to Senator Ron Wyden.

AMGA submits letter to Senate Finance Committee regarding healthcare data transparency The American Medical Group Association today submitted formal comments to the Senate Financing Committee regarding healthcare data transparency. The letter, resolved to Senator Ron Wyden, chairman of the Committee on Finance, and Senator Chuck Grassley, highlighted how multispecialty medical organizations and other organized systems of care and attention are using data to improve quality and lower costs. Using claims and clinical data and predictive analytics, these medical groups have the ability to identify sufferers with chronic conditions that need intense management.Van der Gaast for the CROSS Group: Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer With new diagnoses in a lot more than 480,000 patients annually, esophageal cancer may be the eighth most common cancer worldwide.1 It really is a lethal disease highly, causing more than 400,000 deaths each year.2 The incidence of esophageal adenocarcinoma is rapidly increasing, whereas that of squamous-cell carcinoma continues to be unchanged.3 Despite sufficient preoperative staging, 25 percent of patients treated with primary surgery have microscopically positive resection margins , and the 5-year survival rate rarely exceeds 40 percent.4 The role of neoadjuvant chemoradiotherapy has been debated for many decades.